Amylyx Pharmaceuticals, Inc. AMLX Increase Decrease In Operating Lease Right Of Use Assets
Increase Decrease In Operating Lease Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amlx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s increase decrease in operating lease right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s increase decrease in operating lease right of use assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported increase decrease in operating lease right of use assets of $300K in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s increase decrease in operating lease right of use assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s increase decrease in operating lease right of use assets decreased by 41.7% year-over-year, from $515K to $300K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s increase decrease in operating lease right of use assets?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s increase decrease in operating lease right of use assets has grown at a 1.9% compound annual growth rate (CAGR), from $1.64M to $1.73M.
- What does increase decrease in operating lease right of use assets mean?
- This represents the change in the carrying value of right-of-use assets associated with operating leases, excluding amortization. It reflects adjustments due to lease modifications, terminations, or changes in lease terms. This metric is used to reconcile non-cash lease activity within the operating section of the cash flow statement.